Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001378210 | SCV001575731 | likely pathogenic | 3-methylcrotonyl-CoA carboxylase 1 deficiency | 2024-01-21 | criteria provided, single submitter | clinical testing | This sequence change falls in intron 6 of the MCCC1 gene. It does not directly change the encoded amino acid sequence of the MCCC1 protein. It affects a nucleotide within the consensus splice site. This variant is present in population databases (rs768630906, gnomAD 0.06%). This variant has been observed in individuals with 3 methylcrotonyl-CoA carboxylase deficiency (PMID: 24078573, 25382614). ClinVar contains an entry for this variant (Variation ID: 1067048). Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Studies have shown that this variant alters mRNA splicing and is expected to lead to the loss of protein expression (PMID: 25382614). In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. |
Fulgent Genetics, |
RCV001378210 | SCV002790659 | likely pathogenic | 3-methylcrotonyl-CoA carboxylase 1 deficiency | 2024-05-10 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV001378210 | SCV004191949 | likely pathogenic | 3-methylcrotonyl-CoA carboxylase 1 deficiency | 2024-02-14 | criteria provided, single submitter | clinical testing |